+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Home Blood Testing Devices Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • February 2024
  • Region: Global
  • Expert Market Research
  • ID: 5941096

Global Home Blood Testing Devices Market Outlook

The global home blood testing devices market size was valued at USD 16.4 billion in 2023, driven by increasing prevalence of chronic diseases like diabetes. The market size is anticipated to grow at a CAGR of 10.7% during the forecast period of 2024-2032 to achieve a value of USD 41.1 billion by 2032.

Home Blood Testing Devices: Introduction

Home blood testing devices are compact, user-friendly tools that allow individuals to monitor various health parameters by analyzing small blood samples. Commonly used for checking blood glucose levels in diabetics, coagulation rates in those on anticoagulants, or lipid profiles for cardiovascular health, these devices offer convenience, privacy, and immediate results. They play a crucial role in self-managing chronic conditions, promoting proactive health management, and reducing the need for frequent clinical visits.

Key Trends in the Global Home Blood Testing Devices Market

The rising prevalence of chronic diseases like diabetes is a major driving force behind the growth of the home blood testing devices market. This increase in chronic health conditions is leading to a higher demand for home-based monitoring and testing solutions.

Advances in technology are playing a crucial role in the market's expansion. Innovations in blood testing devices are making them more user-friendly, accurate, and efficient, thus encouraging their adoption among consumers.

The convenience of being able to monitor one's health from the comfort of home is a significant factor in the market's growth. Home blood testing devices offer a convenient alternative to traditional laboratory testing, saving time and making regular monitoring more accessible for patients with chronic conditions.

There's a growing trend of health consciousness among consumers. More people are taking proactive steps towards managing their health, which includes regular monitoring of vital health parameters through home blood testing devices.

Regulatory bodies are increasingly recognizing the importance of home-based health monitoring solutions. This recognition is leading to more supportive policies and guidelines, which in turn is encouraging the development and adoption of home blood testing devices.

Home blood testing devices are increasingly being integrated with digital health platforms, allowing for better data management, analysis, and remote consultation with healthcare professionals. This integration enhances the utility and effectiveness of home blood testing, contributing to market growth.

Global Home Blood Testing Devices Market Segmentation

Market Breakup by Type

  • Glucose Test Kits
  • Infectious Diseases Test Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Test Kits
  • Coagulation Monitoring Tests
  • Others

Market Breakup by Age Group

  • Pediatric
  • Adult
  • Geriatric

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Home Blood Testing Devices Market Overview

In North America, the market for home blood testing devices is highly developed, driven by a growing prevalence of chronic diseases like diabetes and cardiovascular conditions. The United States leads with a high adoption rate of digital health technologies and a strong emphasis on preventive healthcare. Consumers in this region are well-informed and proactive about health monitoring, supported by advanced healthcare infrastructure and widespread availability of sophisticated home testing devices.

Europe presents a mature market for home blood testing devices, characterized by high healthcare standards and a significant focus on home healthcare solutions. Countries such as Germany, the UK, and France are at the forefront, propelled by an aging population, increased prevalence of chronic diseases, and a strong healthcare system. The market is also supported by favorable government initiatives aimed at reducing hospital visits and promoting self-care practices.

The Asia-Pacific region is witnessing rapid growth in the home blood testing devices market. Factors such as rising healthcare awareness, increasing disposable incomes, and a burgeoning middle class contribute to this growth. Countries like China, India, and Japan are experiencing a surge in demand for home healthcare solutions, driven by a growing elderly population, urbanization, and improvements in healthcare infrastructure. However, the market faces challenges such as disparities in healthcare access and awareness.

Global Home Blood Testing Devices Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.
  • ACON Laboratories Inc
  • Quidel Corporation
  • OraSure Technologies Inc
  • Cardinal Health Inc
  • PHC Holdings Corporation
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Biomerieux SA
  • F. Hoffmann-La-Roche Ltd
  • Everly Health Inc
  • Walgreens
  • D&A health
  • Pts Disgnostics
  • Trinity Biotech Plc
  • Siemens Healthineers


This product will be delivered within 5-7 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Home Blood Testing Devices Market Overview
3.1 Global Home Blood Testing Devices Market Historical Value (2017-2023)
3.2 Global Home Blood Testing Devices Market Forecast Value (2024-2032)
4 Global Home Blood Testing Devices Market Landscape
4.1 Global Home Blood Testing Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Home Blood Testing Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Home Blood Testing Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Home Blood Testing Devices Market Segmentation
6.1 Global Home Blood Testing Devices Market by Type
6.1.1 Market Overview
6.1.2 Glucose Test Kits
6.1.3 Infectious Diseases Test Kits
6.1.4 Cholesterol Test Strips
6.1.5 Drugs of Abuse Test Kits
6.1.6 Coagulation Monitoring Tests
6.1.7 Others
6.2 Global Home Blood Testing Devices Market by Age Group
6.2.1 Market Overview
6.2.2 Pediatric
6.2.3 Adult
6.2.4 Geriatric
6.3 Global Home Blood Testing Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Pharmacy
6.3.5 Others
6.4 Global Home Blood Testing Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Home Blood Testing Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Home Blood Testing Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Home Blood Testing Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Home Blood Testing Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Home Blood Testing Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 ACON Laboratories Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quidel Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 OraSure Technologies Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health Inc
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 PHC Holdings Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Abbott Laboratories
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Biomerieux SA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La-Roche Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Everly Health Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Walgreens
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 D&A health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Pts Disgnostics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Trinity Biotech Plc
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthineers
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Home Blood Testing Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Companies Mentioned

  • ACON Laboratories Inc
  • Quidel Corporation
  • OraSure Technologies Inc
  • Cardinal Health Inc
  • PHC Holdings Corporation
  • B. Braun Melsungen AG
  • Abbott Laboratories
  • Biomerieux SA
  • F. Hoffmann-La-Roche Ltd
  • Everly Health Inc
  • Walgreens
  • D&A health
  • Pts Disgnostics
  • Trinity Biotech Plc
  • Siemens Healthineers

Methodology

Loading
LOADING...

Table Information